ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

TRI-PREVIFEM
Acne
Contraception
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

TRI-PREVIFEM Rx

Generic Name and Formulations:
Norgestimate 0.18mg, ethinyl estradiol 35mcg (7 tabs); norgestimate 0.215mg, ethinyl estradiol 35mcg (7 tabs); norgestimate 0.25mg, ethinyl estradiol 35mcg (7 tabs); inert (7 tabs).

Company:
Teva Pharmaceuticals

e-Prescribe this drug via Surescripts


Therapeutic Use:

Product Resources »
  • Product Information
  • Coupons, Samples & Vouchers
  • Patient Education and Assistance

Indications for TRI-PREVIFEM:

Moderate acne vulgaris in females ≥15 years of age, who have no known contraindications to oral contraceptive therapy, desire contraception, have achieved menarche, and are unresponsive to topical anti-acne medications.

Adult Dose for TRI-PREVIFEM:

1 tab daily for 28 days; repeat.

Children's Dose for TRI-PREVIFEM:

Not applicable.

Pharmacological Class:

Progestin + estrogen.

Contraindications:

Thrombophlebitis or thromboembolic disorders. Cerebral vascular or coronary artery disease. Breast or other estrogen-dependent neoplasms. Undiagnosed abnormal genital bleeding. Cholestatic jaundice of pregnancy or jaundice with prior OC use. Hepatic adenoma or carcinoma. Pregnancy (Cat.X).

Warnings/Precautions:

Smokers over 35 years of age: not recommended. Uncontrolled hypertension. Hypertriglyceridemia. Discontinue if jaundice, visual disturbances, migraine or other severe headaches occur. Do regular complete physical exams. May need barrier contraception with Sunday starts or postpartum use (see literature). Nursing mothers: not recommended.

Interactions:

Antagonized by hepatic enzyme inducing drugs (eg, rifampin, griseofulvin, St. John's wort), possibly others. May affect measurement of sex hormone-binding globulin levels.

Adverse Reactions:

Hypertension, nausea, vomiting, breakthrough bleeding, amenorrhea, transient delay of ovulation after discontinuation, edema, chloasma, mastodynia, headache, intolerance to contact lenses. Increased risk of gallbladder disease, thromboembolic disorders.

How Supplied:

Packs—1

TRI-PREVIFEM

  • 28 tablets packages (Qty:1)
  • appx. price $44.00
GoodRx

Indications for TRI-PREVIFEM:

Oral contraception.

Adult Dose for TRI-PREVIFEM:

1 tab daily for 28 days; repeat.

Children's Dose for TRI-PREVIFEM:

Not applicable.

Pharmacological Class:

Progestin + estrogen.

Contraindications:

Thrombophlebitis or thromboembolic disorders. Cerebral vascular or coronary artery disease. Breast or other estrogen-dependent neoplasms. Undiagnosed abnormal genital bleeding. Cholestatic jaundice of pregnancy or jaundice with prior OC use. Hepatic adenoma or carcinoma. Pregnancy (Cat.X).

Warnings/Precautions:

Smokers over 35 years of age: not recommended. Uncontrolled hypertension. Hypertriglyceridemia. Discontinue if jaundice, visual disturbances, migraine or other severe headaches occur. Do regular complete physical exams. May need barrier contraception with Sunday starts or postpartum use (see literature). Nursing mothers: not recommended.

Interactions:

Antagonized by hepatic enzyme inducing drugs (eg, rifampin, griseofulvin, St. John's wort), possibly others. May affect measurement of sex hormone-binding globulin levels.

Adverse Reactions:

Hypertension, nausea, vomiting, breakthrough bleeding, amenorrhea, transient delay of ovulation after discontinuation, edema, chloasma, mastodynia, headache, intolerance to contact lenses. Increased risk of gallbladder disease, thromboembolic disorders.

How Supplied:

Packs—1

TRI-PREVIFEM

  • 28 tablets packages (Qty:1)
  • appx. price $44.00
GoodRx

Sign Up for Free e-newsletters